| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |